Skip to main content
Top
Published in: BMC Neurology 1/2019

Open Access 01-12-2019 | Multiple Sclerosis | Research article

Multiple sclerosis and stroke: a systematic review and meta-analysis

Authors: Ye Hong, Huai Rong Tang, Mengmeng Ma, Ning Chen, Xin Xie, Li He

Published in: BMC Neurology | Issue 1/2019

Login to get access

Abstract

Background

Multiple sclerosis (MS) and stroke are two common causes of death and disability worldwide. The relationship between these two diseases remains unclear. Effective early preventative measures and treatments are available to reduce the morbidity and mortality of acute stroke. The objectives of our systematic review are to estimate the risk of stroke in patients with MS and to collate related studies to draw preliminary conclusions that may improve clinical practice.

Method

Relevant studies were systematically searched in MEDLINE, Embase, the Chinese Biomedical Literature Database (CBM), the China National Knowledge Infrastructure and the VIP database of Chinese periodicals from January 1983 to May 2017, with no restrictions on language. Patients included in this review were adults who suffered from MS. Review Manager 5.3 software program was used to pool data and calculate the risk ratio (RR) and its 95% confidence interval (CI). We also performed heterogeneity and sensitivity analyses and evaluated bias in the meta-analysis.

Results

Nine studies including more than 380,000 participants that met our inclusion criteria were incorporated into the meta-analysis. During different follow-up periods, patients with MS had an increased risk of any type of stroke [RR = 3.48, 95% CI (1.59, 7.64), P = 0.002 for 1 year; RR = 2.45, 95% CI (1.90, 3.16), P < 0.00001 for 10–13 years]. The total prevalence of stroke (any type) in patients with MS exceeded expectations compared to different groups [Comparing with general veteran: RR = 2, 95% CI (1.19, 3.38), P = 0.009. Comparing with general population: RR = 2.93, 95% CI (1.13, 7.62), P = 0.03]. Furthermore, ischemic stroke was particularly more common in the MS population than in people without MS [RR = 6.09, 95% CI (3.44, 10.77), P < 0.00001].

Conclusion

Compared with the general population, people with MS have an increased risk of developing any type of stroke and ischemic stroke in particular. Consistent results were obtained from patients of different sexes and age groups. Preventative measures and treatments should be administered at earlier time points to improve patient outcomes.
Appendix
Available only for authorised users
Literature
1.
go back to reference Karussis D. The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review. J Autoimmun. 2014;(2–3):134–42.CrossRef Karussis D. The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review. J Autoimmun. 2014;(2–3):134–42.CrossRef
2.
go back to reference Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology. 1996;46:907–11.CrossRef Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology. 1996;46:907–11.CrossRef
4.
go back to reference Eskandarieh S, Heydarpour P, et al. Multiple Sclerosis Epidemiology in East Asia, South East Asia and South Asia: A Systematic Review. Neuroepidemiology. 2016;46:209–21.CrossRef Eskandarieh S, Heydarpour P, et al. Multiple Sclerosis Epidemiology in East Asia, South East Asia and South Asia: A Systematic Review. Neuroepidemiology. 2016;46:209–21.CrossRef
5.
go back to reference Lai CH, Tseng HF. Population-based epidemiological study of neurological diseases in Taiwan: I. Creutzfeldt Jakob disease and multiple sclerosis. Neuroepidemiology. 2009;33:247–53.CrossRef Lai CH, Tseng HF. Population-based epidemiological study of neurological diseases in Taiwan: I. Creutzfeldt Jakob disease and multiple sclerosis. Neuroepidemiology. 2009;33:247–53.CrossRef
6.
go back to reference Zhou WB, Cui YZ, Bo X. Studies of Epidemiological of Multiple Sclerosis. Chinese Journal of Neuroimmunology and Neurology. 2005;12:373–5. Zhou WB, Cui YZ, Bo X. Studies of Epidemiological of Multiple Sclerosis. Chinese Journal of Neuroimmunology and Neurology. 2005;12:373–5.
7.
go back to reference Li SJ, Wu WP, Huang DH, et al. Analysis of clinical features and prognosis of multiple sclerosis. J Clin Neurol. 2009;22. Li SJ, Wu WP, Huang DH, et al. Analysis of clinical features and prognosis of multiple sclerosis. J Clin Neurol. 2009;22.
8.
go back to reference Capkun G, Dahlke F, Lahoz R, et al. Mortality and comorbidities in patients with multiple sclerosis compared with a population without multiple sclerosis: An observational study using the US Department of Defense administrative claims database. Mult Scler Relat Disord. 2015;4(6):546–54.CrossRef Capkun G, Dahlke F, Lahoz R, et al. Mortality and comorbidities in patients with multiple sclerosis compared with a population without multiple sclerosis: An observational study using the US Department of Defense administrative claims database. Mult Scler Relat Disord. 2015;4(6):546–54.CrossRef
9.
go back to reference Fleming ST. Multiple sclerosis as a comorbidity: A study of resource utilization and outcomes of care. Clin Perform Qual Health Care. 1995;3:23–30.PubMed Fleming ST. Multiple sclerosis as a comorbidity: A study of resource utilization and outcomes of care. Clin Perform Qual Health Care. 1995;3:23–30.PubMed
10.
go back to reference Marrie RA, Reider N, Cohen J, et al. A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis. Mult Scler. 2015;21:318–31.CrossRef Marrie RA, Reider N, Cohen J, et al. A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis. Mult Scler. 2015;21:318–31.CrossRef
11.
go back to reference Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis Of Observational Studies in Epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology(MOOSE) group. JAMA. 2000;283(15):2008–12.CrossRef Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis Of Observational Studies in Epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology(MOOSE) group. JAMA. 2000;283(15):2008–12.CrossRef
12.
go back to reference Tseng CH, Huang WS, Lin CL, et al. Increased risk of ischaemic stroke among patients with multiple sclerosis. Eur J Neurol. 2015;22:500–6.CrossRef Tseng CH, Huang WS, Lin CL, et al. Increased risk of ischaemic stroke among patients with multiple sclerosis. Eur J Neurol. 2015;22:500–6.CrossRef
13.
go back to reference Kang JH, Chen YH, Lin HC. Comorbidities amongst patients with multiple sclerosis: A population- based controlled study. Eur J Neurol. 2000;17:1215–9.CrossRef Kang JH, Chen YH, Lin HC. Comorbidities amongst patients with multiple sclerosis: A population- based controlled study. Eur J Neurol. 2000;17:1215–9.CrossRef
14.
go back to reference Thormann A, Magyari M, Koch-Henriksen N, et al. Vascular comorbidities in multiple sclerosis: a nationwide study from Denmark. J Neurol. 2016;263:2484–93.CrossRef Thormann A, Magyari M, Koch-Henriksen N, et al. Vascular comorbidities in multiple sclerosis: a nationwide study from Denmark. J Neurol. 2016;263:2484–93.CrossRef
15.
go back to reference Allen NB, Lichtman JH, Cohen HW, et al. Vascular disease among hospitalized multiple sclerosis patients. Neuroepidemiology. 2008;30:234–8.CrossRef Allen NB, Lichtman JH, Cohen HW, et al. Vascular disease among hospitalized multiple sclerosis patients. Neuroepidemiology. 2008;30:234–8.CrossRef
16.
go back to reference Lavela SL, Prohaska TR, Furner S, et al. Chronic diseases in male veterans with multiple sclerosis. Prev Chronic Dis. 2012;9:E55.PubMedPubMedCentral Lavela SL, Prohaska TR, Furner S, et al. Chronic diseases in male veterans with multiple sclerosis. Prev Chronic Dis. 2012;9:E55.PubMedPubMedCentral
17.
go back to reference Zöller B, Li X, Sundquist J, et al. Risk of subsequent ischemic and hemorrhagic stroke in patients hospitalized for immunemediated diseases: a nationwide follow-up study from Sweden. BMC Neurol. 2012;12:41.CrossRef Zöller B, Li X, Sundquist J, et al. Risk of subsequent ischemic and hemorrhagic stroke in patients hospitalized for immunemediated diseases: a nationwide follow-up study from Sweden. BMC Neurol. 2012;12:41.CrossRef
18.
go back to reference Christiansen CF, Christensen S, Farkas DK, et al. Risk of arterial cardiovascular diseases in patients with multiple sclerosis: a population-based cohort study. Neuroepidemiology. 2010;35:267–74.CrossRef Christiansen CF, Christensen S, Farkas DK, et al. Risk of arterial cardiovascular diseases in patients with multiple sclerosis: a population-based cohort study. Neuroepidemiology. 2010;35:267–74.CrossRef
19.
go back to reference Jadidi E, Mohammadi M, Moradi T. High risk of cardiovascular diseases after diagnosis of multiple sclerosis. Mult Scler. 2013;19:1336–40.CrossRef Jadidi E, Mohammadi M, Moradi T. High risk of cardiovascular diseases after diagnosis of multiple sclerosis. Mult Scler. 2013;19:1336–40.CrossRef
20.
go back to reference Milo R, Kahana E. Multiple sclerosis: geoepidemiology, genetics and the environment. Autoimmun Rev. 2010;9:A387–94.CrossRef Milo R, Kahana E. Multiple sclerosis: geoepidemiology, genetics and the environment. Autoimmun Rev. 2010;9:A387–94.CrossRef
21.
go back to reference Choy E, Ganeshalingam K, Semb AG, et al. Cardiovascular risk in rheumatoid arthritis: Recent advances in the understanding of the pivotal role of inflammation,risk predictors and the impact of treatment. Rheumatology (Oxford). 2014;53(12):2143–54.CrossRef Choy E, Ganeshalingam K, Semb AG, et al. Cardiovascular risk in rheumatoid arthritis: Recent advances in the understanding of the pivotal role of inflammation,risk predictors and the impact of treatment. Rheumatology (Oxford). 2014;53(12):2143–54.CrossRef
22.
go back to reference Szpecht D, Gadzinowski J, Seremak-Mrozikiewicz A, et al. The significance of polymorphisms in genes encoding il-1beta, il-6, tnfalpha, and il-1rn in the pathogenesis of intraventricular hemorrhage in preterm infants. Childs Nerv Syst. 2017;33(11):1905–16.CrossRef Szpecht D, Gadzinowski J, Seremak-Mrozikiewicz A, et al. The significance of polymorphisms in genes encoding il-1beta, il-6, tnfalpha, and il-1rn in the pathogenesis of intraventricular hemorrhage in preterm infants. Childs Nerv Syst. 2017;33(11):1905–16.CrossRef
23.
go back to reference Puz P, Lasek-Bal A. Repeated measurements of serum concentrations of tnfalpha, interleukin-6 and interleukin-10 in the evaluation of internal carotid artery stenosis progression. Atherosclerosis. 2017;263:97–103.CrossRef Puz P, Lasek-Bal A. Repeated measurements of serum concentrations of tnfalpha, interleukin-6 and interleukin-10 in the evaluation of internal carotid artery stenosis progression. Atherosclerosis. 2017;263:97–103.CrossRef
24.
go back to reference Blasi C. The autoimmune origin of atherosclerosis. Atherosclerosis. 2008;201:17–32.CrossRef Blasi C. The autoimmune origin of atherosclerosis. Atherosclerosis. 2008;201:17–32.CrossRef
25.
go back to reference Brück W. The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage. J Neurol. 2005; 252:V/3-V/9.CrossRef Brück W. The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage. J Neurol. 2005; 252:V/3-V/9.CrossRef
26.
go back to reference Khan F, Pallant J, Brand C. Caregiver strain and factors associated with caregiver self-efficacy and quality of life in a community cohort with multiple sclerosis. Disabil Rehabil. 2007;29:1241–50.CrossRef Khan F, Pallant J, Brand C. Caregiver strain and factors associated with caregiver self-efficacy and quality of life in a community cohort with multiple sclerosis. Disabil Rehabil. 2007;29:1241–50.CrossRef
27.
go back to reference Krökki O, Bloigu R, Ansakorpi H, et al. Neurological comorbidity and survival in multiple sclerosis. Mult Scler Relat Disord. 2013;3:72–7.CrossRef Krökki O, Bloigu R, Ansakorpi H, et al. Neurological comorbidity and survival in multiple sclerosis. Mult Scler Relat Disord. 2013;3:72–7.CrossRef
28.
go back to reference Nuyen J, Schellevis FG, Satariano WA, et al. Comorbidity was associated with neurologic and psychiatric diseases: A general practice-based controlled study. J Clin Epidemiol. 2006;59:1274–84.CrossRef Nuyen J, Schellevis FG, Satariano WA, et al. Comorbidity was associated with neurologic and psychiatric diseases: A general practice-based controlled study. J Clin Epidemiol. 2006;59:1274–84.CrossRef
29.
go back to reference Fleming ST, Blake RL Jr. Patterns of comorbidity in elderly patients with multiple sclerosis. J Clin Epidemiol. 1994;47(10):1127–1132.CrossRef Fleming ST, Blake RL Jr. Patterns of comorbidity in elderly patients with multiple sclerosis. J Clin Epidemiol. 1994;47(10):1127–1132.CrossRef
30.
go back to reference Johnston SC, Mendis S, Mathers CD. Global variation in stroke burden and mortality: Estimates from monitoring, surveillance, and modelling. Lancet Neurol. 2009;8:345–54.CrossRef Johnston SC, Mendis S, Mathers CD. Global variation in stroke burden and mortality: Estimates from monitoring, surveillance, and modelling. Lancet Neurol. 2009;8:345–54.CrossRef
31.
go back to reference Feigin VL, Lawes CM, Bennett DA, et al. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: A systematic review. Lancet Neurol. 2009;8:355–69.CrossRef Feigin VL, Lawes CM, Bennett DA, et al. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: A systematic review. Lancet Neurol. 2009;8:355–69.CrossRef
32.
go back to reference Slawta JN, Wilcox AR, McCubbin JA, et al. Health behaviors, body composition, and coronary heart disease risk in women with multiple sclerosis. Arch Phys Med Rehabil. 2003;84:1823–30.CrossRef Slawta JN, Wilcox AR, McCubbin JA, et al. Health behaviors, body composition, and coronary heart disease risk in women with multiple sclerosis. Arch Phys Med Rehabil. 2003;84:1823–30.CrossRef
33.
go back to reference Egesten A, Brandt L, Olsson T, et al. Increased prevalence of multiple sclerosis among COPD patients and their first-degree relatives: a population-based study. Lung. 2008;186:173–8.CrossRef Egesten A, Brandt L, Olsson T, et al. Increased prevalence of multiple sclerosis among COPD patients and their first-degree relatives: a population-based study. Lung. 2008;186:173–8.CrossRef
34.
go back to reference Chang KH, Lyu RK, Chen CM, et al. Clinical characteristics of multiple sclerosis in Taiwan: a cross-sectional study. Mult Scler. 2006; 8(12):501–506.CrossRef Chang KH, Lyu RK, Chen CM, et al. Clinical characteristics of multiple sclerosis in Taiwan: a cross-sectional study. Mult Scler. 2006; 8(12):501–506.CrossRef
35.
go back to reference Brønnum-Hansen H, Koch-Henriksen N, Stenager E. Trends in survival and cause of death in Danish patients with Multiple Sclerosis. Brain. 2004;127:844–50.CrossRef Brønnum-Hansen H, Koch-Henriksen N, Stenager E. Trends in survival and cause of death in Danish patients with Multiple Sclerosis. Brain. 2004;127:844–50.CrossRef
36.
go back to reference Poser CM, Paty DW, Scheinberg LC. New Diagnostic Criteria for Multiple Sclerosis: Guidelines for Research Protocols. Ann Neurol. 1983;13:227–31.CrossRef Poser CM, Paty DW, Scheinberg LC. New Diagnostic Criteria for Multiple Sclerosis: Guidelines for Research Protocols. Ann Neurol. 1983;13:227–31.CrossRef
37.
go back to reference Poser CM. Onset Symptoms in Multiple Sclerosis. J Neurol Neurosurg Psychiatry. 1995;58:253–4.CrossRef Poser CM. Onset Symptoms in Multiple Sclerosis. J Neurol Neurosurg Psychiatry. 1995;58:253–4.CrossRef
38.
go back to reference McDonald WI, Compston A, Edan G, et al. Recommended Diagnostic Criteria for Multiple Sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol. 200l. 50:121–7. McDonald WI, Compston A, Edan G, et al. Recommended Diagnostic Criteria for Multiple Sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol. 200l. 50:121–7.
39.
go back to reference Chris H, Stephen C, Gilles Edan. Diagnostic Criteria for Multiple sclerosis:2005 Revisions to the “McDonald Criteria”. Ann Neurol. 2005; 58:840–846. Chris H, Stephen C, Gilles Edan. Diagnostic Criteria for Multiple sclerosis:2005 Revisions to the “McDonald Criteria”. Ann Neurol. 2005; 58:840–846.
40.
go back to reference Polman CH, Reingold SC, BanwelI B, et al. Diagnostic Criteria for multiple sclerosis:2010 Revisions to the McDonald Criteria. Ann Neurol. 2011;69:292–302.CrossRef Polman CH, Reingold SC, BanwelI B, et al. Diagnostic Criteria for multiple sclerosis:2010 Revisions to the McDonald Criteria. Ann Neurol. 2011;69:292–302.CrossRef
41.
go back to reference Allen CL, Bayraktutan U. Risk factors for ischemic stroke. Int J Stroke. 2008;3:105–16.CrossRef Allen CL, Bayraktutan U. Risk factors for ischemic stroke. Int J Stroke. 2008;3:105–16.CrossRef
42.
go back to reference Harmsen P, Lappas G, Rosengren A, et al. Long-term risk factors for stroke: twenty-eight years of follow-up of 7457 middle-aged men in G€oteborg, Sweden. Stroke. 2006; 37:1663–1667.CrossRef Harmsen P, Lappas G, Rosengren A, et al. Long-term risk factors for stroke: twenty-eight years of follow-up of 7457 middle-aged men in G€oteborg, Sweden. Stroke. 2006; 37:1663–1667.CrossRef
43.
go back to reference Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation. 2010;121:e46–215.PubMed Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation. 2010;121:e46–215.PubMed
44.
go back to reference Munger KL, Bentzen J, Laursen B, et al. Childhood body mass index and multiple sclerosis risk: a long-term cohort study. Mult Scler. 2013; 9(19): 1323–1329.CrossRef Munger KL, Bentzen J, Laursen B, et al. Childhood body mass index and multiple sclerosis risk: a long-term cohort study. Mult Scler. 2013; 9(19): 1323–1329.CrossRef
45.
go back to reference Freedman DS, Patel DA, Srinivasan SR, et al. The contribution of childhood obesity to adult carotid intima-media thickness: the Bogalusa heart study. Int J Obes (Lond). 2008;32(5):749–56.CrossRef Freedman DS, Patel DA, Srinivasan SR, et al. The contribution of childhood obesity to adult carotid intima-media thickness: the Bogalusa heart study. Int J Obes (Lond). 2008;32(5):749–56.CrossRef
46.
go back to reference Munger KL, Levin LI, Hollis BW, et al. Serum 25-hydroxy vitamin D levels and risk of multiple sclerosis. JAMA. 2006;296(23):2832–8.CrossRef Munger KL, Levin LI, Hollis BW, et al. Serum 25-hydroxy vitamin D levels and risk of multiple sclerosis. JAMA. 2006;296(23):2832–8.CrossRef
47.
go back to reference Thacker EL, Mirzaei F, Ascherio A. Infectious mononucleosis and risk for multiple sclerosis: a meta- analysis. Ann Neurol. 2006;59(3):499–503.CrossRef Thacker EL, Mirzaei F, Ascherio A. Infectious mononucleosis and risk for multiple sclerosis: a meta- analysis. Ann Neurol. 2006;59(3):499–503.CrossRef
48.
go back to reference Goldstein LB, Bushnell CD, Adams RJ, et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2010;42:517–84.CrossRef Goldstein LB, Bushnell CD, Adams RJ, et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2010;42:517–84.CrossRef
49.
go back to reference de Boer OJ, Teeling P, Idu MM, et al. Epstein Barr virus specific T-cells generated from unstable human atherosclerotic lesions: implications for plaque inflammation. Atherosclerosis. 2006;184:322–9.CrossRef de Boer OJ, Teeling P, Idu MM, et al. Epstein Barr virus specific T-cells generated from unstable human atherosclerotic lesions: implications for plaque inflammation. Atherosclerosis. 2006;184:322–9.CrossRef
50.
go back to reference Straus SE, Majumdar SR, McAlister FA. New evidence for stroke prevention: Scientific review. JAMA. 2002;288:1388–95.CrossRef Straus SE, Majumdar SR, McAlister FA. New evidence for stroke prevention: Scientific review. JAMA. 2002;288:1388–95.CrossRef
51.
go back to reference Wakefield AJ, More LJ, Difford J, et al. Immunohistochemical study of vascular injury in acute multiple sclerosis. J Clin Pathol. 1994;47:129–33.CrossRef Wakefield AJ, More LJ, Difford J, et al. Immunohistochemical study of vascular injury in acute multiple sclerosis. J Clin Pathol. 1994;47:129–33.CrossRef
52.
go back to reference Lassmann H. Hypoxia-like tissue injury as a component of multiple sclerosis lesions. J Neurol Sci. 2003;206:187–91.CrossRef Lassmann H. Hypoxia-like tissue injury as a component of multiple sclerosis lesions. J Neurol Sci. 2003;206:187–91.CrossRef
53.
go back to reference Christiansen CF. Risk of vascular disease in patients with multiple sclerosis: A review. Neurol Res. 2012;34(8):746–53.CrossRef Christiansen CF. Risk of vascular disease in patients with multiple sclerosis: A review. Neurol Res. 2012;34(8):746–53.CrossRef
54.
go back to reference Wei L, MacDonald TM, Walker BR. Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Ann Intern Med. 2004;141(10):764–70.CrossRef Wei L, MacDonald TM, Walker BR. Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Ann Intern Med. 2004;141(10):764–70.CrossRef
55.
go back to reference Morra VB, Coppola G, Orefice G, et al. Interferon-beta treatment decreases cholesterol plasma levels in multiple sclerosis patients. Neurology. 2004;62(5):829–30.CrossRef Morra VB, Coppola G, Orefice G, et al. Interferon-beta treatment decreases cholesterol plasma levels in multiple sclerosis patients. Neurology. 2004;62(5):829–30.CrossRef
56.
go back to reference Sternberg Z, Leung C, Sternberg D, et al. Disease modifying therapies modulate cardiovascular risk factors in patients with multiple sclerosis. Cardiovasc Ther. 2014;32(2):33–9.CrossRef Sternberg Z, Leung C, Sternberg D, et al. Disease modifying therapies modulate cardiovascular risk factors in patients with multiple sclerosis. Cardiovasc Ther. 2014;32(2):33–9.CrossRef
57.
58.
go back to reference Zhang X, Shu XO, Gao YT, et al. Pregnancy, childrearing, and risk of stroke in Chinese women. Stroke. 2009;40:2680–4.CrossRef Zhang X, Shu XO, Gao YT, et al. Pregnancy, childrearing, and risk of stroke in Chinese women. Stroke. 2009;40:2680–4.CrossRef
59.
go back to reference Roshanisefat H, Bahmanyar S, Hillert J, et al. Multiple sclerosis clinical course and cardiovascular disease risk-Swedish cohort study. Eur J Neurol. 2014; 21(11):1353-e88.CrossRef Roshanisefat H, Bahmanyar S, Hillert J, et al. Multiple sclerosis clinical course and cardiovascular disease risk-Swedish cohort study. Eur J Neurol. 2014; 21(11):1353-e88.CrossRef
60.
go back to reference Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis:2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162–73. Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis:2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162–73.
Metadata
Title
Multiple sclerosis and stroke: a systematic review and meta-analysis
Authors
Ye Hong
Huai Rong Tang
Mengmeng Ma
Ning Chen
Xin Xie
Li He
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2019
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-019-1366-7

Other articles of this Issue 1/2019

BMC Neurology 1/2019 Go to the issue